Related Experiment Video
Updated: Mar 31, 2026
Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
Published on: September 18, 2015
In vitro and in vivo cell-capture strategies using cardiac stent technology - A review
Rohan R Ravindranath1, Alexander Romaschin2, Michael Thompson3
1Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada; Keenan Research Centre and Clinical Biochemistry, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario M5B 1W8, Canada.
Insights
New stent designs aim to prevent restenosis after heart surgery by capturing cells and reducing immune response. This review explores innovative cell-capture methods for improved coronary artery disease treatment.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Materials Science
Background:
- Coronary artery disease (CAD) involves arterial narrowing, often treated with cardiac stents.
- Restenosis, or re-narrowing of the artery post-stenting, is a significant complication driven by immune response.
- Current treatments for restenosis remain a major clinical challenge.
Purpose of the Study:
- To review emerging cell-capture strategies for mitigating stent-induced restenosis.
- To explore diverse methods for enhancing stent biocompatibility and reducing adverse immune reactions.
- To present an overview of in vitro and in vivo cell-capture techniques.
Main Methods:
- Investigating biological stent modifications.
- Utilizing surface science for biological probe immobilization.
- Examining protein and nucleotide immobilization techniques.
- Evaluating the application of magnetic fields for cell capture.
Main Results:
- Cell-capture stents show promise in reducing immune responses.
- Biological modifications and surface functionalization are key strategies.
- Diverse immobilization techniques offer tailored approaches to cell capture.
Conclusions:
- Cell-capture technology presents a promising avenue for combating restenosis.
- Further research into stent-based cell capture can significantly improve patient outcomes in CAD.
- Future prospects include refining existing methods and developing novel cell-capture systems.
Abstract:
Stenosis is a symptom of coronary artery disease (CAD), and is caused by narrowing of arteries in the heart. Over the last several decades, medical implants such as cardiac stents have been developed to counter stenosis. Upon implantation of a stent to open up a restricted artery, narrowing of the artery can reoccur (restenosis), due to an immune response launched by the body towards the stent. Currently, restenosis is a major health concern for patients who have undergone heart surgery for coronary artery disease. Recently, there have been new methods developed to combat restenosis, which have shown potential signs of success. One proposed method is the use of stents to capture cells, thereby reducing immune response. This review will explore the different methods for cell capture both in vitro and in vivo. Biological modifications of the stent will be surveyed, as well as the use of surface science to immobilize biological probes. Immobilization of proteins and nucleotides, as well as use of magnetic field are all methods that will be further discussed. Finally, concluding remarks and future prospects will be presented.
